XML 49 R37.htm IDEA: XBRL DOCUMENT v3.5.0.2
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2016
Stockholders' Equity  
Schedule of key assumptions to determine fair value of options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

 

September 30, 

 

September 30, 

 

 

 

    

2016

    

2015

    

2016

    

2015

 

 

Average volatility

 

31.9

%  

27.5

%  

30.4

%

27.1

%

 

Risk-free interest rate

 

1.3

%  

2.0

%  

1.5

%

1.3

%

 

Weighted-average expected life in years

 

6.3

 

6.3

 

5.5

 

4.5

 

 

Dividend yield rate

 

 —

%  

 —

%  

 —

%

 —

%

 

 

Schedule of the summary of option activity under all plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

Weighted-Average

 

Remaining

 

Aggregate

 

 

 

 

 

Exercise

 

Contractual

 

Intrinsic

 

 

 

Options

 

Price

 

Term (Years)

 

Value(1)

 

 

 

 

 

 

 

 

 

 

(in thousands)

 

Outstanding as of December 31, 2015

    

12,240,467

    

$

15.41

    

    

    

 

    

 

Options granted

 

2,395,789

 

 

12.19

 

 

 

 

 

 

Options exercised

 

(1,262,020)

 

 

13.93

 

 

 

 

 

 

Options cancelled

 

(174,783)

 

 

13.48

 

 

 

 

 

 

Options expired

 

(245,538)

 

 

23.84

 

 

 

 

 

 

Outstanding as of September 30, 2016

 

12,953,915

 

$

14.82

 

4.50

 

$

67,739

 

Exercisable as of September 30, 2016

 

8,183,715

 

$

15.59

 

2.99

 

$

41,704

 


The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the estimated fair value of the Company’s common stock for those awards that have an exercise price below the estimated fair value at September 30, 2016.

Schedule of information relating to options grants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

September 30, 

 

September 30, 

 

 

    

2016

    

2015

    

2016

    

2015

 

 

 

(in thousands, except per share data)

 

Weighted-average grant date fair value

 

$

6.34

 

$

4.54

 

$

3.42

 

$

3.44

 

Intrinsic value of options exercised

 

 

4,998

 

 

268

 

 

5,980

 

 

2,721

 

Cash received

 

 

14,331

 

 

816

 

 

17,584

 

 

11,257

 

Total fair value of the options vested during the year

 

 

2,688

 

 

2,888

 

 

7,948

 

 

5,423

 

 

Schedule of the summary of nonvested options status

 

 

 

 

 

 

 

 

    

 

    

Weighted-Average

 

 

 

 

 

Grant Date

 

 

 

Options

 

Fair Value

 

Nonvested as of December 31, 2015

 

5,202,095

 

$

3.44

 

Options granted

 

2,395,789

 

 

3.42

 

Options vested

 

(2,652,901)

 

 

3.00

 

Options forfeited

 

(174,783)

 

 

4.67

 

Nonvested as of September 30, 2016

 

4,770,200

 

 

3.63

 

 

Schedule of information relating to RSU grants and deliveries

 

 

 

 

 

 

 

 

 

 

 

 

Total Fair Market

 

 

 

 

 

Value of RSUs

 

 

 

 

 

Issued

 

 

 

Total RSUs

 

as

 

 

    

Issued

    

Compensation(1)

 

 

 

 

 

(in thousands)

 

RSUs outstanding at December 31, 2015

 

866,540

 

 

 

 

RSUs granted

 

732,021

 

$

8,646

 

RSUs forfeited

 

(53,157)

 

 

 

 

Common stock delivered

 

(218,875)

 

 

 

 

RSUs surrendered for taxes

 

(108,457)

 

 

 

 

RSUs outstanding at September 30, 2016

 

1,218,072

 

 

 

 


The total fair market value is derived from the number of RSUs granted times the current stock price on the date of grant.

Schedule of recorded share-based compensation expense under all plans

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

September 30, 

 

September 30, 

 

 

 

2016

 

2015

 

2016

 

2015

 

 

 

(in thousands)

 

Cost of revenues

    

$

675

    

$

638

    

$

2,245

    

$

1,856

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, distribution, and marketing

 

 

45

 

 

49

 

 

176

 

 

148

 

General and administrative

 

 

2,593

 

 

2,536

 

 

8,339

 

 

6,676

 

Research and development

 

 

242

 

 

204

 

 

844

 

 

677

 

Total share-based compensation

 

$

3,555

 

$

3,427

 

$

11,604

 

$

9,357

 

 

Schedule of changes in stockholders' equity

 

 

 

 

 

 

 

 

Nine Months

 

 

 

Ended

 

 

 

September 30, 

 

 

    

2016

 

 

 

(in thousands)

 

 

 

 

 

 

Stockholders’ equity as of December 31, 2015

 

$

295,510

 

 Net income

 

 

13,274

 

 Accumulated other comprehensive loss

 

 

(106)

 

 Exercise of stock options

 

 

17,584

 

 Issuance of common stock to employees under the ESPP

 

 

915

 

 Nonemployee share-based compensation expense

 

 

1,122

 

 Employee share-based compensation expense

 

 

10,482

 

 Repurchase of common stock(1)

 

 

(1,342)

 

 Purchase of treasury stock

 

 

(8,986)

 

Stockholders’ equity as of September 30, 2016

 

$

328,453

 


(1)

Repurchase of common stock relating to the tax withholding of equity award settlements.